Papers

2

Total Citations

28

H-Index

2

About

Dr. Seong Taek Oh is a leading colorectal surgeon whose research bridges the frontiers of multimodal cancer therapy and minimally invasive surgical innovation. His most impactful work centers on optimizing treatment protocols for rectal cancer, where he demonstrated through a landmark phase II multi-institutional trial (KROG 11-02) that a two-week course of preoperative chemoradiotherapy followed by delayed surgery yields favorable outcomes—a contribution cited over 25 times that challenges conventional long-course regimens. More recently, Dr. Oh has pioneered the application of robotic surgery in hernia repair, authoring the first prospective pilot study to confirm the safety and feasibility of single-incision robotic totally extra-peritoneal inguinal hernia repair using the da Vinci Xi platform. This work, though early in its citation trajectory, signals a paradigm shift toward scarless, precision-driven approaches. Beyond these contributions, Dr. Oh’s research portfolio reflects a commitment to reducing surgical morbidity while maintaining oncologic rigor. His work continues to influence clinical guidelines and inspire a new generation of surgeons to integrate evidence-based neoadjuvant strategies with cutting-edge robotic techniques.

Research Focus

Key Achievements

2
H-Index
2
Papers
28
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: A phase II multi-institutional clinical trial (KROG 11-02)
25 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Catholic University of Korea, The Catholic University of Korea Uijeongbu St. Mary's Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago